IAM
KERX

Iridian Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Iridian Asset Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-220,600
Closed -$1.6M – 85
2017
Q2 		$1.6M Sell
220,600
-44,510
-17% -$322K 0.01% 65
2017
Q1 		$1.63M Buy
265,110
+36,540
+16% +$225K 0.01% 64
2016
Q4 		$1.34M Buy
+228,570
New +$1.34M 0.01% 65